Our team has launched and exited several high-growth startups, reinvesting exit gains alongside accredited investors in 20+ companies.
As founders and business angels, we deeply understand the unique financial needs of life science startups, ensuring strategies that drive growth and long-term success.
Through our flagship DxPx Conference and the 42plus1 business plan competition, we’ve built a personal network of international investors across Europe, the U.S., and Asia. Leverage our connections to unlock new opportunities and funding.
From securing early-stage funding to structuring complex M&A deals, our team of serial entrepreneurs, seasoned bankers, and M&A managers is equipped to guide you through every financial milestone.
We only accept mandates where we would — and typically do — invest ourselves, ensuring full alignment with the startups we support.
Ready to take your startup to the next level? Connect with us today and discover how we can help your business succeed in the diagnostics, digital health, and life science tools industry.
Use our scientific, medical knowledge, our own entrepreneurial background and IPO experience to find the right investor and facilitate communication.
Examination of economic and legal condition of term sheets.
Approval of company valuation/purchase price and final agreement conditions.
Serial Entrepreneur and MD of SilverSky LifeSciences & SLS Solutions